Poitiers University Hospital
π«π·France
- Country
- π«π·France
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.chu-poitiers.fr
Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients
Phase 1
Terminated
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-11-28
- Lead Sponsor
- Poitiers University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT00219765
- Locations
- π«π·
University Hospital, Poitiers, France
Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2012-08-29
- Lead Sponsor
- Poitiers University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT00219726
- Locations
- π«π·
University Hospital, Poitiers, France
STI571 ProspectIve RandomIzed Trial: SPIRIT
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- Poitiers University Hospital
- Target Recruit Count
- 789
- Registration Number
- NCT00219739
- Locations
- π«π·
University Hospital, Poitiers, France
Evaluation of Pain Intensity During Bone Marrow Biopsy Performed With Inhalation of Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture.
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-09-22
- Lead Sponsor
- Poitiers University Hospital
- Target Recruit Count
- 280
- Registration Number
- NCT00219713
- Locations
- π«π·
University Hospital, Poitiers, France
Β© Copyright 2024. All Rights Reserved by MedPath